Characteristic | N = 50 | |
---|---|---|
Age (years) | Median (IQR) | 66.0 (57.8–68.0) |
Sex | Male | 42 (84.0%) |
Female | 8 (16.0%) | |
Smoking history | Ever | 35 (70.0%) |
Never | 15 (30.0%) | |
Stage | IIB | 4 (8.0%) |
IIIA | 24 (48.0%) | |
IIIB | 16 (32.0%) | |
IIIC | 6 (12.0%) | |
PD-L1 expression | <1% | 11 (22.0%) |
1–49% | 8 (16.0%) | |
>49% | 5 (10.0%) | |
Unknown | 26 (52.0%) | |
Histopathology | Squamous cell carcinoma | 32 (64.0%) |
Adenocarcinoma | 9 (18.0%) | |
NSCLC-NOS | 9 (18.0%) | |
Treatment cycle | 1 | 2 (4.0%) |
2 | 18 (36.0%) | |
3 | 15 (30.0%) | |
4 | 15 (30.0%) |